Menu
Close
ANALYSIS SERVICES
chevron_right
DRUG DISCOVERY
chevron_right
NEWS
chevron_right
ABOUNT US
chevron_right
CONTACT
chevron_right
Language
expand_more
Japanese
chevron_right
Close
Top
NEWS
NEWS
Stay informed about the latest NEWS from SOCIUM.
2024-09-17
SOCIUM Inc. and Huaxi Hospital of Sichuan University have decided to conduct an investigator-initiated clinical trial of SO-002, a drug candidate for the treatment of amyotrophic lateral sclerosis (ALS)
2024-06-07
AI drug discovery venture that takes on the challenge of overcoming “unmet medical needs, SOCIUM Inc.’s paper was published in The Journal of Biomedical Research
2024-06-05
株式投資型クラウドファンディングの実施 及び オンライン事業説明会開催のお知らせ
2024-01-11
Announcement of a Strategic Alliance for the Development of Drugs for the Treatment of Rare Diseases in China
2023-10-03
Our Paper on Phosphorylation Analysis Accepted through Collaboration with Nanjing Medical University School of Pharmacy (China)
2023-09-19
Exhibit at “Japan Healthcare Venture Summit 2023”
2023-01-30
SOCIUM Inc Announces to be Awarded Third Prize in The World at JINJI LAKE STARTUP CONTEST 2022
2022-05-25
RaQualia Pharma and SOCIUM Sign Joint Research Agreement for Discovering The Orphan Indication for Compound by Using AI Technology.
2022-03-15
Sumitomo Dainippon Pharma to Collaborate with SOCIUM Joint Research Aims to Reveal Neuroprotective Mechanism in Tauopathy
2022-01-11
Tokushima University to Collaborate with SOCIUM Inc. Strategic partnership aims to AI-driven drug discovery for Rare Gastrointestinal Tumor
1
2
3
Next »